CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03406780
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:45.449469+00:00
Published At: 2025-02-24T00:00:00+00:00
Record Updated At: 2025-05-28
Results Posted At: 2025-02-24
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Muscular Dystrophies", "Muscular Dystrophy, Duchenne", "Muscular Disorders, Atrophic", "Muscular Diseases", "Neuromuscular Diseases", "Nervous System Diseases", "Genetic Diseases, X-Linked", "Genetic Diseases, Inborn"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-05-28"
protocolSection.identificationModule.nctId: "NCT03406780"
protocolSection.identificationModule.officialTitle: "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-02-24"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.